跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DEPO-MEDROL methylprednisolone acetate 40 mg/1 mL injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
DEPO-MEDROL methylprednisolone acetate 40 mg/1 mL injection vial
Approved
STANDARD
DEPO-MEDROL methylprednisolone acetate 40 mg/1 mL injection vial
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
be3b959b25f79a4e
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
be3b959b25f79a4e
Product Name
DEPO-MEDROL methylprednisolone acetate 40 mg/1 mL injection vial
Artg Id
12299
Artg Name
DEPO-MEDROL methylprednisolone acetate 40 mg/1 mL injection vial
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
1991-08-02
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/d3c447d3805ad723d5e25490117d994d.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/7f2204d94b54df929f1f47f65477b3ab.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
be3b959b25f79a4e
Type
Standard
Back to TGA Approvals